Our findings provide mechanistic evidence suggesting microglial JunB, as a switch molecule, induced by the neighboring melanoma cells to harness microglia in their favor, and targeting this specific microglia subpopulation may serve as a therapy for brain-metastasizing melanoma. This evidence concerns the gene JUNB and melanoma.